sources: 14988
Data license: CC-BY
This data as json
id | name | description | createdAt | updatedAt | datasetId | additionalInfo | link | dataPublishedBy |
---|---|---|---|---|---|---|---|---|
14988 | Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines | { "link": "http://apps.who.int/gho/data/node.home", "retrievedDate": "23-March-18", "additionalInfo": "Indicator name\nEstimated number of people needing antiretroviral therapy\n\nName abbreviated\n\n \n\nData Type Representation\nCount\n\nTopic\n\n \n\nISO Health Indicators Framework\n\n \n\nRationale\nAs the HIV pandemic matures, increasing numbers of people are reaching advanced stages of HIV\ninfection. Antiretroviral therapy (ART) has been shown to reduce mortality amongst those infected and\nefforts are being made to make it more affordable within low- and middle-income countries.\n\nDefinition\nFor ADULTS: National HIV prevalence curves are used as a basis for calculating the numbers of people eligible for antiretroviral therapy. Several factors influence the number of adults eligible, including the CD4 count threshold at which antiretroviral\ntherapy is deemed necessary. In 2010, WHO recommended that the threshold be changed from 200 cells per mm3 to 350 cells per mm3\n\u2013 substantially increasing the number of people eligible for antiretroviral therapy in low- and middle-income countries.\nSpectrum (software developed by WHO/UNAIDS) tracks the number of adults living with HIV according to their CD4 count. This enables precise\nestimates of the numbers of adults who are eligible for antiretroviral therapy and of the number of people dying from AIDS-related causes.\nFor CHILDREN: The Spectrum software package is used to estimate the number of children up to the age of 15 living with HIV; the same estimate is used to identify the number of children who need antiretroviral therapy. These estimates require assumptions about fertility among women living with HIV, the efficacy of various prophylaxis regimens to prevent mother-to-child transmission, the timing of progression between different CD4 levels and children\u2019s survival rates (depending, for example, on how and at what age they became infected).\n\nAssociated terms\n\n \n\nPreferred data sources\n\n \n\nOther possible data sources\n\n \n\nMethod of measurement\n\n \n\nMethod of estimation\nFor ADULTS: National HIV prevalence curves are used as a basis for calculating the numbers of people eligible for antiretroviral therapy. Several factors influence the number of adults eligible, including the CD4 count threshold at which antiretroviral\ntherapy is deemed necessary. In 2010, WHO recommended that the threshold be changed from 200 cells per mm3 to 350 cells per mm3\n\u2013 substantially increasing the number of people eligible for antiretroviral therapy in low- and middle-income countries.\nSpectrum (software developed by WHO/UNAIDS) tracks the number of adults living with HIV according to their CD4 count. This enables precise\nestimates of the numbers of adults who are eligible for antiretroviral therapy and of the number of people dying from AIDS-related causes.\nFor CHILDREN: the 2010 WHO treatment guidelines recommend that all children younger than 24 months living with HIV be provided with antiretroviral therapy regardless of CD4 counts.\n\nM&E Framework\n\n \n\nMethod of estimation of global and regional aggregates\n\n \n\nDisaggregation\nAge\n\nDisaggregation\nSex\n\nUnit of Measure\n\n \n\nUnit Multiplier\n\n \n\nExpected frequency of data dissemination\n\n \n\nExpected frequency of data collection\n\n \n\nLimitations\n\n \n\nLinks\n\n \n\nComments\n\n \n\nContact Person\n\n \n\n", "dataPublishedBy": "World Health Organization Global Health Observatory (GHO)", "dataPublisherSource": null } |
2018-03-23 12:42:56 | 2018-03-23 12:42:56 | 2694 | Indicator name Estimated number of people needing antiretroviral therapy Name abbreviated Data Type Representation Count Topic ISO Health Indicators Framework Rationale As the HIV pandemic matures, increasing numbers of people are reaching advanced stages of HIV infection. Antiretroviral therapy (ART) has been shown to reduce mortality amongst those infected and efforts are being made to make it more affordable within low- and middle-income countries. Definition For ADULTS: National HIV prevalence curves are used as a basis for calculating the numbers of people eligible for antiretroviral therapy. Several factors influence the number of adults eligible, including the CD4 count threshold at which antiretroviral therapy is deemed necessary. In 2010, WHO recommended that the threshold be changed from 200 cells per mm3 to 350 cells per mm3 – substantially increasing the number of people eligible for antiretroviral therapy in low- and middle-income countries. Spectrum (software developed by WHO/UNAIDS) tracks the number of adults living with HIV according to their CD4 count. This enables precise estimates of the numbers of adults who are eligible for antiretroviral therapy and of the number of people dying from AIDS-related causes. For CHILDREN: The Spectrum software package is used to estimate the number of children up to the age of 15 living with HIV; the same estimate is used to identify the number of children who need antiretroviral therapy. These estimates require assumptions about fertility among women living with HIV, the efficacy of various prophylaxis regimens to prevent mother-to-child transmission, the timing of progression between different CD4 levels and children’s survival rates (depending, for example, on how and at what age they became infected). Associated terms Preferred data sources Other possible data sources Method of measurement Method of estimation For ADULTS: National HIV prevalence curves are used as a basis for calculating the numbers of people eligible for antiretroviral therapy. Several factors influence the number of adults eligible, including the CD4 count threshold at which antiretroviral therapy is deemed necessary. In 2010, WHO recommended that the threshold be changed from 200 cells per mm3 to 350 cells per mm3 – substantially increasing the number of people eligible for antiretroviral therapy in low- and middle-income countries. Spectrum (software developed by WHO/UNAIDS) tracks the number of adults living with HIV according to their CD4 count. This enables precise estimates of the numbers of adults who are eligible for antiretroviral therapy and of the number of people dying from AIDS-related causes. For CHILDREN: the 2010 WHO treatment guidelines recommend that all children younger than 24 months living with HIV be provided with antiretroviral therapy regardless of CD4 counts. M&E Framework Method of estimation of global and regional aggregates Disaggregation Age Disaggregation Sex Unit of Measure Unit Multiplier Expected frequency of data dissemination Expected frequency of data collection Limitations Links Comments Contact Person | http://apps.who.int/gho/data/node.home | World Health Organization Global Health Observatory (GHO) |
Links from other tables
- 1 row from sourceId in variables